Joel Greenblatt’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-22,400
Closed -$176K – 1892
2026
Q2
$176K Buy
22,400
+1,834
+9% +$14.5K ﹤0.01% 1741
2026
Q1
$140K Sell
20,566
-4,609
-18% -$34.1K ﹤0.01% 1713
2025
Q4
$293K Sell
25,175
-6,190
-20% -$68.4K ﹤0.01% 1569
2025
Q3
$365K Buy
+31,365
New +$379K ﹤0.01% 1467

Other funds holding CRMD

Joel Greenblatt's CRMD Position: Q3 2026 in Review

Joel Greenblatt sold out of CorMedix (CRMD) in Q3 2026, closing a stake of 22,400 shares — an estimated $176K sold.

Joel Greenblatt first reported a position in CRMD in Q3 2025 and held it in 4 quarters. The position peaked at $365K in Q3 2025. 189 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.

  • Joel Greenblatt reported no remaining CorMedix position as of Q3 2026 after selling out during the quarter.
  • Joel Greenblatt sold 22,400 CorMedix shares in Q3 2026, an estimated $176K.
  • Joel Greenblatt first reported a position in CorMedix in Q3 2025 and held it in 4 quarters.
  • Joel Greenblatt's CorMedix position peaked at $365K in Q3 2025.
  • 189 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.